|
Volumn 87, Issue 6, 2001, Pages
|
Signaling proteins as innovative targets for antineoplastic therapy: Our experience with the signaling protein c-Myc
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTIMETABOLITE;
ANTIMITOTIC AGENT;
ANTINEOPLASTIC AGENT;
DNA TOPOISOMERASE INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FLUOROURACIL;
GEFITINIB;
GYRASE INHIBITOR;
IMATINIB;
STABILIZING AGENT;
TRASTUZUMAB;
INTERCALATING AGENT;
MYC PROTEIN;
ANTINEOPLASTIC ACTIVITY;
CANCER CELL;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CELL DIVISION;
CELL PROLIFERATION;
CONFERENCE PAPER;
DNA MODIFICATION;
DRUG CLASSIFICATION;
DRUG SYNTHESIS;
DRUG TARGETING;
HISTORY OF MEDICINE;
HUMAN;
ISOPRENYLATION;
NONHUMAN;
ONCOGENE C MYC;
ONCOGENE NEU;
SIGNAL TRANSDUCTION;
ARTICLE;
CANCER CENTER;
IN VITRO STUDY;
IN VIVO STUDY;
MITOSIS SPINDLE;
PERSONAL EXPERIENCE;
PROTEIN TARGETING;
|
EID: 0035746356
PISSN: 03008916
EISSN: None
Source Type: Journal
DOI: 10.1177/030089160108700636 Document Type: Conference Paper |
Times cited : (10)
|
References (10)
|